RxDoctor Payments DataLook up a doctor →

Brooke Halpern, MD

Internal Medicine · Savannah, GANPI 1184158248

Payments from drug & device makers

$185,272in general payments, 2019–2025

Across 728 payments — averaging $254.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$131K
  • Qiagen, LLC$42K
  • AbbVie$2K
  • Novo Nordisk$1K
  • Amgen$1K
  • Pfizer$1K
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)18$131,484
Qiagen, LLC1$41,945
AbbVie(2 entities)139$1,882
Novo Nordisk101$1,233
Amgen(2 entities)44$1,050
Pfizer49$1,040
Novartis51$689
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC35$532
Otsuka America Pharmaceutical, Inc.22$481
Lilly USA, LLC24$449
Lundbeck LLC17$322
Boehringer Ingelheim16$307
Johnson & Johnson15$269
Dexcom, Inc.12$251
Merck17$243
GSK15$236
Teva Pharmaceuticals USA, Inc.11$184
Bayer9$164
Lucid Diagnostics Inc.2$163
Idorsia Pharmaceuticals US Inc7$146
Esperion Therapeutics, Inc.11$135
Radius Health, Inc.5$134
Exact Sciences8$124
Mylan Specialty L.p.5$114
Sumitomo Pharma America, Inc.6$110
Bausch Health US, LLC3$102
Ironwood Pharmaceuticals, Inc5$101
Amarin Pharma, Inc.6$92
Axsome Therapeutics, Inc.4$86
Currax Pharmaceuticals LLC6$83
Antares Pharma, Inc.4$78
Eisai Inc.4$64
Biohaven Pharmaceuticals, Inc.3$63
Kowa Pharmaceuticals America, Inc.4$57
Phathom Pharmaceuticals, Inc.4$52
Evofem Biosciences, Inc.3$49
Biohaven Pharmaceutical Holding Company Ltd.2$46
Pulmonx Corporation1$45
Sanofi Pasteur Inc.3$45
IBSA Pharma Inc.3$42
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$37
Sanofi-aventis U.S. LLC2$36
Medtronic2$36
Sunovion Pharmaceuticals Inc.2$34
Arbor Pharmaceuticals, Inc.2$34
Madrigal Pharmaceuticals2$34
Genentech USA, Inc.2$30
Halozyme Inc1$29
Xeris Pharmaceuticals, Inc.1$25
Boston Scientific1$24
Scynexis, Inc.1$23
VBI Vaccine (delaware) Inc.1$22
Cvrx, Inc.1$22
Ardelyx, Inc.1$19
Corcept Therapeutics1$18
UCB, Inc.1$18
Abiomed1$18
Baxter Healthcare1$17
Inspire Medical Systems, Inc.1$16
Sanofi1$16

How this compares

$185,272 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Medicare billing

Part B allowed, 2024
$361,170
Medicare patients
639
Services billed
6,826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Savannah

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →